Pages that link to "Q30450509"

The following pages link to Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection (Q30450509):

Displaying 15 items.

• The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation (Q21131166) (← links)
• Metabolic insights from zebrafish genetics, physiology, and chemical biology (Q28084257) (← links)
• An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation. (Q30253082) (← links)
• The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation (Q30409961) (← links)
• Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation (Q30415616) (← links)
• Targeting of adenosine receptors in ischemia-reperfusion injury (Q30429069) (← links)
• Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation (Q30430008) (← links)
• Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation (Q30430239) (← links)
• Therapeutic applications (Q37874187) (← links)
• Role of adenosine signalling and metabolism in β-cell regeneration (Q38169437) (← links)
• Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond. (Q38272552) (← links)
• Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging (Q38765118) (← links)
• The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice (Q40946206) (← links)
• Adenosine signaling promotes regeneration of pancreatic β cells in vivo (Q42197940) (← links)
• Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism). (Q55709806) (← links)